83-5960-79 TNF alpha, Infliximab Biosimilar 1mg 587272
特徴
- Infliximab, a chimeric anti-TNF-alpha monoclonal antibody, is used to treat psoriasis, Crohn's disease, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis.
- Infliximab interferes TNF-alpha from binding to its receptor in the cell.
- Mainly produced by activated macrophages (M1), Tumor necrosis factor (TNF, cachexin, cachectin, tumor necrosis factor alpha, TNF alpha) plays important roles in the regulation of autoimmune reaction.
- Applications:Suitable for use in ELISA, Neutralization, Functional Assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by Infliximab.
- Other applications not tested.
- Recommended Dilution:Optimal dilutions to be determined by the researcher.
- Storage and Stability:May be stored at 4℃ for short-term only.
- Aliquot to avoid repeated freezing and thawing.
- Store at -20℃.
- Aliquots are stable for 12 months after receipt.
- For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
- Size：1mg
- 抗体種類：Mab
- 宿主：human
- Source Antibody：human
- Grade：Highly Purified
- Purity：≥95% by reducing SDS-PAGE, HPLC. Endotoxin: ≤1EU/mg (LAL).
- Form：Supplied as a 0.2uM filtered solution, pH 7.2. No stabilizers or preservatives added.
- Specificity：Recognizes the Infliximab biosimilar which specifically binds to the human TNF alpha.
- Isotype：IgG1,k
- Calc Applications Abbrev：E N
- Calc Crossreactivity：Hu
- Immunogen：Recombinant human TNF alpha, expressed in CHO cells.
- この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
- 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
- 【試薬に関するお問合せ】
- アズワン株式会社 試薬・プロセス材料グループ
- TEL：06-6447-8641
- FAX：06-6447-8642
- E-mail：[email protected]
商品のバリエーション （サイズ違い・スペック違い・オプション品など）
| 商品イメージ | アズワン品番 商品名 |
|---|---|
|
83-5960-79
TNF alpha, Infliximab Biosimilar 1mg
|
|
|
83-5960-80
TNF alpha, Infliximab Biosimilar 5mg
|
よくあるご質問（FAQ）
掲載カタログ情報
| 掲載カタログ名 | 掲載ページ |
|---|